163 related articles for article (PubMed ID: 29535107)
21. Focal amyotrophy in neurofibromatosis 2.
Trivedi R; Byrne J; Huson SM; Donaghy M
J Neurol Neurosurg Psychiatry; 2000 Aug; 69(2):257-61. PubMed ID: 10896706
[TBL] [Abstract][Full Text] [Related]
22. Childhood neurofibromatosis type 2 (NF2) and related disorders: from bench to bedside and biologically targeted therapies.
Ruggieri M; Praticò AD; Serra A; Maiolino L; Cocuzza S; Di Mauro P; Licciardello L; Milone P; Privitera G; Belfiore G; Di Pietro M; Di Raimondo F; Romano A; Chiarenza A; Muglia M; Polizzi A; Evans DG
Acta Otorhinolaryngol Ital; 2016 Oct; 36(5):345-367. PubMed ID: 27958595
[TBL] [Abstract][Full Text] [Related]
23. Clinical course of vestibular schwannoma in pediatric neurofibromatosis Type 2.
Choi JW; Lee JY; Phi JH; Wang KC; Chung HT; Paek SH; Kim DG; Park SH; Kim SK
J Neurosurg Pediatr; 2014 Jun; 13(6):650-7. PubMed ID: 24724714
[TBL] [Abstract][Full Text] [Related]
24. Natural history of neurofibromatosis type 2 with onset before the age of 1 year.
Ruggieri M; Gabriele AL; Polizzi A; Salpietro V; Nicita F; Pavone P; Platania N; Milone P; Distefano A; Privitera G; Belfiore G; Granata F; Caltabiano R; Albanese V; Pavone L; Quattrone A
Neurogenetics; 2013 May; 14(2):89-98. PubMed ID: 23377185
[TBL] [Abstract][Full Text] [Related]
25. Unilateral vestibular schwannoma with other neurofibromatosis type 2-related tumors: clinical and molecular study of a unique phenotype.
Aghi M; Kluwe L; Webster MT; Jacoby LB; Barker FG; Ojemann RG; Mautner VF; MacCollin M
J Neurosurg; 2006 Feb; 104(2):201-7. PubMed ID: 16509493
[TBL] [Abstract][Full Text] [Related]
26. Renal vascular disease in neurofibromatosis type 2: association or coincidence?
Cordeiro NJ; Gardner KR; Huson SM; Stewart H; Elston JS; Howard EL; Tullus KO; Pike MG
Dev Med Child Neurol; 2006 Jan; 48(1):58-9. PubMed ID: 16359595
[TBL] [Abstract][Full Text] [Related]
27. Cerebral vasculopathy in childhood neurofibromatosis type 2: cause for concern?
Lascelles K; Afridi S; Siddiqui A; Hemingway C; Ferner R; Ganesan V
Dev Med Child Neurol; 2018 Dec; 60(12):1285-1288. PubMed ID: 29781505
[TBL] [Abstract][Full Text] [Related]
28. Vestibular schwannoma growth in patients with neurofibromatosis Type 2: a longitudinal study.
Mautner VF; Baser ME; Thakkar SD; Feigen UM; Friedman JM; Kluwe L
J Neurosurg; 2002 Feb; 96(2):223-8. PubMed ID: 11838794
[TBL] [Abstract][Full Text] [Related]
29. Multiple meningiomas: differential involvement of the NF2 gene in children and adults.
Evans DG; Watson C; King A; Wallace AJ; Baser ME
J Med Genet; 2005 Jan; 42(1):45-8. PubMed ID: 15635074
[TBL] [Abstract][Full Text] [Related]
30. Diagnosis, Management, and New Therapeutic Options in Childhood Neurofibromatosis Type 2 and Related Forms.
Ruggieri M; Praticò AD; Evans DG
Semin Pediatr Neurol; 2015 Dec; 22(4):240-58. PubMed ID: 26706012
[TBL] [Abstract][Full Text] [Related]
31. Neurofibromatosis Type 2.
Ardern-Holmes S; Fisher G; North K
J Child Neurol; 2017 Jan; 32(1):9-22. PubMed ID: 27655473
[TBL] [Abstract][Full Text] [Related]
32. Identification of mutations in the NF2 gene in Polish patients with neurofibromatosis type 2.
Łaniewski-Wołłk M; Gos M; Koziarski A; Szpecht-Potocka A
J Appl Genet; 2008; 49(3):297-300. PubMed ID: 18670066
[TBL] [Abstract][Full Text] [Related]
33. Multiple schwannomas: schwannomatosis or neurofibromatosis type 2?
Seppälä MT; Sainio MA; Haltia MJ; Kinnunen JJ; Setälä KH; Jääskeläinen JE
J Neurosurg; 1998 Jul; 89(1):36-41. PubMed ID: 9647170
[TBL] [Abstract][Full Text] [Related]
34. A patient with mosaic neurofibromatosis type 2 presenting with early onset meningioma.
Chu YW; Cheuk DK; Chung BH; Bowers NL; Ha SY; Chiang AK; Chan GC
BMJ Case Rep; 2014 Nov; 2014():. PubMed ID: 25406210
[TBL] [Abstract][Full Text] [Related]
35. Ophthalmologic findings and long-term course in patients with neurofibromatosis type 2.
Bosch MM; Boltshauser E; Harpes P; Landau K
Am J Ophthalmol; 2006 Jun; 141(6):1068-1077. PubMed ID: 16765675
[TBL] [Abstract][Full Text] [Related]
36. [Neurofibromatosis type 2 (NF2)--classical example of a rare familial cancer syndrome].
Wiszniewski W
Med Wieku Rozwoj; 1999; 3(1):47-54. PubMed ID: 10910638
[TBL] [Abstract][Full Text] [Related]
37. Combined retinal hamartomas leading to the diagnosis of neurofibromatosis type 2.
Grant EA; Trzupek KM; Reiss J; Crow K; Messiaen L; Weleber RG
Ophthalmic Genet; 2008 Sep; 29(3):133-8. PubMed ID: 18766994
[TBL] [Abstract][Full Text] [Related]
38. [Type 2 neurofibromatosis: intergenerational differences in genetic and clinical expression].
Drouet A; Le Moigne F; Salamé D; Quesnel L; Motolese C; des Portes V; Guilloton L; Pinson S
Arch Pediatr; 2014 Nov; 21(11):1233-40. PubMed ID: 25439059
[TBL] [Abstract][Full Text] [Related]
39. A genetic study of type 2 neurofibromatosis in the United Kingdom. I. Prevalence, mutation rate, fitness, and confirmation of maternal transmission effect on severity.
Evans DG; Huson SM; Donnai D; Neary W; Blair V; Teare D; Newton V; Strachan T; Ramsden R; Harris R
J Med Genet; 1992 Dec; 29(12):841-6. PubMed ID: 1479598
[TBL] [Abstract][Full Text] [Related]
40. Clinical and molecular predictors of mortality in neurofibromatosis 2: a UK national analysis of 1192 patients.
Hexter A; Jones A; Joe H; Heap L; Smith MJ; Wallace AJ; Halliday D; Parry A; Taylor A; Raymond L; Shaw A; Afridi S; Obholzer R; Axon P; King AT; ; Friedman JM; Evans DG
J Med Genet; 2015 Oct; 52(10):699-705. PubMed ID: 26275417
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
